版本:
中国

BRIEF-Cerveau Technologies says finalization of a clinical supply agreement with Merck

May 4 Cerveau Technologies Inc

* Cerveau Technologies Inc. Signs clinical supply agreement with merck for investigational tau imaging agent

* Cerveau Technologies says finalization of a clinical supply agreement with merck

* Cerveau Technologies- will be responsible for providing access to MK-6240 at multiple sites globally to be used in Merck-specific research initiatives

* Cerveau Technologies- will be accelerating technology transfer and site qualification in over 15 sites to provide access to support broad availability Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐